The 2009 H1N1 pandemic tested the limits of the public health emergency preparedness systems in the US and abroad. The successes and failures from this pandemic remain relevant, particularly as pathogens like MER-CoV and Ebola continue to proliferate. The Public Health Response to 2009 H1N1: A Systems Perspective draws lessons from the public health system's response to the influenza pandemic, offering a collection of chapters that are highly relevant to all public health emergencies. Not simply a historical case study, this analysis employs a systems perspective that encompasses both government health agencies and community-based entities such as care providers, schools, and media. This title demonstrates rigorous qualitative research approaches that can be used to analyze public health system responses to both pathogens and a wide variety of other public health emergencies.
Table of Contents
- Chapter 1 Introduction
- Chapter 2 Did Advances in Global Surveillance and Notification Systems Make a Difference in the 2009 H1N1 Pandemic?
- Chapter 3 The Effectiveness of U.S. Public Health Surveillance Systems for Situational Awareness during the 2009 H1N1 Pandemic
- Chapter 4 Variability in School Closure Decisions in Response to 2009 H1N1
- Chapter 5 Wearing Many Hats: Lessons about Emergency Preparedness and Routine Public Health from the H1N1 Response
- Chapter 6 Variation in the Local Management of Publicly Purchased Antiviral Drugs during the 2009 H1N1 Influenza Pandemic
- Chapter 7 The H1N1 Response from the Perspective of State and Territorial Immunization Program Managers: Managing the Vaccination Campaign
- Chapter 8 Implementing a National Vaccination Campaign at the State and Local Levels: Massachusetts Case Study
- Chapter 9 The Italian Response to the 2009 H1N1 Pandemic
- Chapter 10 Local Health Department Vaccination Success during 2009 H1N1
- Chapter 11 Public Communication during the 2009 H1N1 Pandemic
- Chapter 12 Obstacles to pH1N1 Vaccine Availability: The Complex Contracting Relationship between Vaccine Manufacturers, the World Health Organization, Donor and Beneficiary Governments
- Chapter 13 Implications for Policy and Practice